Kenya experiences a substantial burden of dengue, yet there are very few DENV-2 sequence data 11 available from this country and indeed the entire continent of Africa. We therefore undertook whole 12 genome sequencing and evolutionary analysis of fourteen dengue virus (DENV)-2 strains sampled from 13 Malindi sub-County Hospital during the 2017 DENV-2 outbreak in the Kenyan coast. We further 14 performed an extended East African phylogenetic analysis, which leveraged 26 complete African env 15 genes. Maximum likelihood analysis showed that the 2017 outbreak was due to the Cosmopolitan 16 genotype, indicating that this has been the only confirmed human DENV-2 genotype circulating in 17 Africa to date. Phylogeographic analyses indicated transmission of DENV-2 viruses between East Africa 18 and South/South-West Asia. Time-scaled genealogies show that DENV-2 viruses are spatially structured 19 within Kenya, with a time-to-most-common-recent ancestor analysis indicating that these DENV-2 20 strains were circulating for up to 5.38 years in Kenya before detection in the 2017 Malindi outbreak. 3 41 performed selection pressure analyses and identified possible new markers of DENV-2 immune 42 recognition specific to this population, with relevance to vaccine design. 43 44
2 21 Selection pressure analyses indicated sampled Kenyan DENV strains uniquely being under positive 22 selection at 6 sites, predominantly across the non-structural genes, and epitope prediction analyses 23 showed that one of these sites corresponds to a putative predicted MHC-I CD8+ DENV-2 Cosmopolitan 24 virus epitope only evident in a sampled Kenyan virus. Taken together, our findings indicate that the 25 2017 Malindi DENV-2 outbreak arose from a strain which had circulated for several years in Kenya 26 before recent detection, has experienced diversifying selection pressure, and may contain new 27 putative immunogens relevant to vaccine design. These findings prompt further genomic 28 epidemiology studies in this and other Kenyan locations to further elucidate the transmission dynamics 29 of DENV in this region. 30 Author summary (non-technical): 31 Kenya experiences a substantial burden of dengue, yet the patterns of dengue spread in this region are 32 unclear. Evolutionary analyses of dengue virus strain sequences could offer major insights into the 33 spread of dengue viruses in this region, but there are very few DENV-2 sequence data available from 34 this country and indeed the entire continent of Africa. We therefore undertook whole genome 35 sequencing and evolutionary analysis of fourteen dengue virus (DENV)-2 strains sampled from Malindi 36 sub-County Hospital during the 2017 DENV-2 outbreak in the Kenyan coast. We further performed an 37 extended East African phylogenetic analysis, which leveraged 26 complete African env genes. Our 38 results indicated transmission of DENV-2 viruses between East Africa and South/South-West Asia, that 39 there is localized spread of DENV-2 viruses within Kenya, and that Kenyan DENV-2 strains were 40 circulating for up to 5.38 years in Kenya before detection in the 2017 Coastal outbreak. We further due to the rapid urbanization of tropical regions, and in part due to the incomplete cross protection 71 offered by a primary dengue infection [7] . Current countermeasures for dengue include vector control 72 and optimized medical management following established guidelines. There is currently only one 73 licensed dengue vaccine (Dengvaxia), which has been implemented in Brazil and the Philippines, and 74 has major safety and effectiveness concerns in dengue unexposed populations [8] . 75 East Africa is thought to have played a key role in the global spread of DENV in the 18th century, with 76 apparent dengue case reports described there as early as 1823. There is a popular -but unproven -77 hypothesis that dengue was introduced into the Caribbean from East Africa [9, 10] . Indeed, the very 78 term 'dengue', is believed to have been derived from the Swahili language (then called 'dinga') [10] . 79 However, compared to other tropical areas, the epidemiology of dengue in East Africa, and Africa in 80 general, is not well understood [7] . This is attributed to limited surveillance and limited availability of 81 diagnostics for dengue, a disease that often has similar clinical symptoms and signs as other endemic 82 tropical diseases in Africa, such as malaria [11, 12] . Further, there are immense competing public 83 health demands in many countries from this region [12] . Nevertheless, the burden of dengue in East 84 Africa is being increasingly recognized. Studies have indicated the circulation of DENV in Kenya To redress this dearth of Kenyan DENV genomic data, and to investigate a recent Kenyan DENV-2 122 outbreak within a phylodynamic framework, we undertook whole genome sequencing and 123 evolutionary analysis of 14 DENV-2 whole genomes. These data represent a major increase to the 124 previously available number of African DENV-2 whole genome data. Specifically, we sought to estimate 125 the duration of cryptic circulation of DENV-2 before first case detections in the 2017 in Malindi 126 outbreak and determine whether this outbreak could be partly explained by viral immune escape. 127 Leveraging these new data and all existing public DENV data, we also performed an extended regional Extracted RNA from an additional four DENV-2 infected sera that failed to sequence in Kenya 156 underwent DENV-2 whole genome sequencing at the Walter Reed Army Institute of Research using in-157 house designed primers which were optimized to the Kenyan DENV-2 sequence data generated by 158 Gathii et al. Amplicons were generated from extracted RNA by these DENV-2 specific primers in 159 addition to random primers. A conventional amplification using DENV-2 specific primers (Table S1) DENV-2 data available on the VIPR and NCBI Genbank databases as of April 2018 [38, 39] (Table S2) . 181 Alignment was performed using MAFFT and manually edited thereafter, before truncation to coding 182 regions [40] . Initial neighbor-joining trees were used to confirm the genotype of these data as the Using these selected HLA molecules we performed MHC-I affinity prediction across sequential 9mer 240 peptides across the entire DENV-2 proteome of all Kenyan whole genome data using the Artificial 241 Neural Network method [50] . We then determined whether any of these predicted 9mer peptides 242 correspond to previously in-vitro studied linear CD8+ or CD4+ epitopes in the IEDB database [51] . 243 Finally, we performed a conservancy analysis of these 9mer peptides to determine whether such 244 putative epitopes are possibly geographically restricted. (Fig 2) . This phylogeny indicates that DENV-2 Kenya African 287 viruses were most closely related to Indian strains (Fig 2) , although the branch length of the Kenyan 288 clade was still long even in the env tree. The sole Uganda strain also clustered with Indian sequences, 289 but its poor branch support also includes the possibility of previous transmissions between Kenya and 290 Uganda (Fig 2) . This extended env analysis also indicated that the strains from the 2011 Somalia Africa and Saudi Arabia (Fig 2) . Asian-African transmission was also inferred in the well supported 296 clustering of a Tanzanian strain in a Chinese clade (Fig 2) . 297 Given the regional importance of this "East-West" African cluster, we performed an extended time-298 scaled Bayesian analysis in BEAST to estimate the geographic history of this endemic DENV-2 lineage, 299 the methodological details of which are indicated in the supplemental Box S1. A maximum clade 300 credibility tree confirmed that Burkina Faso seeded neighboring Ghana outbreaks in 2005, and 301 indicated a high probability of transmission of DENV-2 from Africa into neighboring Saudi Arabia (Fig 3) . 302 This same analysis estimated that this lineage of DENV-2 emerged in Somalia and Burkina Faso as early 303 as 1978 (TMCRA 1981 , 95% HPD 1978 -1983 ) and 1978 (TMRCA 1980 , 95% HPD 1977 -1982 , 304 respectively. The dated root the East-West cluster indicated emergence of this DENV-2 strain in Africa 305 as early as 1975 (TMRCA 1978 , 95% HPD 1975 -1981 . The exact origins of this strain remains unclear, 306 with only moderate probability support for Burkina Faso as the country of emergence (Fig 3) , 307 suggesting that other unsampled African or non-African countries may have played a key role of the 308 early epidemic history of this East-West sublineage. 309 The current 2016-2017 DENV2 outbreak into Malindi arose from strains introduced in 2013 310 311 There was weak evidence only (probability = 0.55) that the recent DENV-2 Cosmopolitan Kenyan clade 312 was originally introduced from India, and this poor statistical support primarily reflects geographic and 313 temporal sampling gaps in Africa (Fig 4) . The time-to-most-common-recent-ancestor of the node which 314 defined all Kenyan Malindi DENV-2 Cosmopolitan strains was estimated at September 2013 (95% 315 credible interval January 2012 -May 2015), thereby indicating that this particular DENV clade has been 316 circulating in Kenya for approximately 3.72 years (2.06 -5.38 years) (Fig 4) , although such an estimate 317 is limited by a paucity of data sampled from other Kenyan locales. This Bayesian analysis estimated the 318 mean evolutionary rate of the entire Cosmopolitan sub-lineage to be 8.94 x 10 -4 subs/site/year (95% 319 credible interval 5.7 x 10 -4 to 1.28 x10 -3 ), which is comparable to other estimates of DENV-2 320 evolutionary rates [7] . We further showed that there was considerable variability in strain evolutionary 321 rate across this entire Cosmopolitan sub-lineage (coefficient of variation = 0.56, 95% credible interval 322 0.31 -0.89) supporting a relaxed molecular clock model. Indeed, there was greater than three-fold 323 variability in the evolutionary rates of the ancestral strains of the Kenyan outbreak alone (range 5 x 10 -4 324 through to 1.8 x 10 -3 substitutions/site/year). Analysis at this spatial scale also indicated that the 325 Kenyan cluster separates into at least two well defined clades with strain co-circulation even at this 326 fine spatial scale, although it is unclear if this represents two distinct introductions of two strains or in-327 situ diversification of a single introduced strain (Fig 4) . 328 Positive selection and immune escape may explain epidemic diversification during the 2017 DENV-2 329 Kenyan outbreak Table 1 shows the codons along the entire genome of the whole DENV-2 Cosmopolitan lineage which 331 are estimated to be under positive selection, and most of these were found on the non-structural 332 genes. Of these seven codon locations, there was strong evidence (positive by three methods) for 333 diversifying selection pressure at codon 1867 which is located in the NS3 gene, and codon 2762 in the 334 NS5 gene. In addition to the above analyses of the Cosmopolitan lineage as a whole, the FEL approach 335 can be used to compare different selection pressures within specific sub-lineages or clades within the 336 dataset (Table 2) . Thus, Kenyan clade was selected to be used as the sub-dataset for selection analyses 337 and compared to the rest of the Cosmopolitan lineage which was set as the background dataset. (Table 3) , the majority across the non-structural proteins. Only three of these have had previous 345 experimental data to support their role as possible CD8+ CTL epitopes and/or CD4+ T-helper cell 346 epitopes (FRKEIGRML, GWGNGCGLF and FTMRLLSPV). While the FRKEIGRML and GWGNGCGLF 347 peptides are highly conserved across all existing published global DENV-2 Cosmopolitan whole genome 348 data, FTMRLLSPV appears to be more geographically restricted to DENV viral populations in South Asia, 349 South West Asia and Kenya (Table 3) . Of the four potential novel epitopes, KMDIGAPLL was not found 350 in any sampled non-Kenyan viral populations suggesting that there may be unique DENV CTL epitopes 351 in those strains circulating Kenya. A position within the TFDSEYIKT epitope was found to be under 352 positive selection for the Cosmopolitan lineage as a whole (Table 1 ), suggesting that this may be a 353 substantial immunogen. Interestingly, one of the predicted CD8+ epitopes, FRKEIGRML in the capsid 354 region, was found within a linear epitope associated with MHC-II positive assays, suggesting that this West Africa, however the implausible lack of evolution for its sampling date rather indicates that this 368 sample actually represents a New Guinea C 1944 contaminant [52] . 369 We showed spatial structure to African DENV-2 epidemics on several scales. On an intercontinental (Table 1) . Another caveat is 396 that dengue virus selection pressure analyses are also inherently susceptible to the size and sampling 397 distribution of the genomic datasets analyzed [7] , and our findings here should be compared and 398 contrasted with other studies sampling dengue viruses in Kenyan and other East African settings, 399 ideally with similar methods. 400 Among the Kenyan sequence data, linear 9mer peptides which flanked the positively selected amino 401 acids specific for the Kenyan genomes (Table 2) 
